Skip to main content

Binita Chakraborty

Research Scientist
Pharmacology & Cancer Biology

Current Appointments & Affiliations


Recent Publications


Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth.

Journal Article Sci Adv · September 27, 2024 Estrogens regulate eosinophilia in asthma and other inflammatory diseases. Further, peripheral eosinophilia and tumor-associated tissue eosinophilia (TATE) predicts a better response to immune checkpoint blockade (ICB) in breast cancer. However, how and if ... Full text Open Access Link to item Cite

Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis

Other · September 16, 2024 <div>Abstract<p>Triple-negative breast cancers (TNBCs) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early stage localized TNBC, the rate of distant recurrence remains h ... Full text Cite

Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis

Other · September 16, 2024 <p>Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4</p> ... Full text Cite
View All Publications

Recent Grants


Manipulating normal estrogen physiology as a therapeutic approach in cancer

ResearchResearch Scientist · Awarded by National Cancer Institute · 2023 - 2028

Development of Novel ERRalpha Antagonists as Breast Cancer Therapeutics

ResearchResearch Scientist · Awarded by National Institutes of Health · 2022 - 2024

Evaluation of the efficacy of a combined regimen including an ER targeted therapy and ICB

ResearchResearch Scientist · Awarded by Sermonix Pharmaceuticals · 2023 - 2024

View All Grants